Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 12, 2004 7:26:59 PM
EDMONTON, ALBERTA--(CCNMatthews - Jun 1, 2004) - AltaRex Medical
Corp. (TSX: ALT) is pleased to announce that the company's
founder and CEO, Dr. Antoine Noujaim, will receive a lifetime
achievement award from the Canadian Society for Pharmaceutical
Sciences. The award recognizes his outstanding and continuous
contributions in the fields of radiopharmaceutics and
biotechnology. Dr. Noujaim will formally accept the award at a
reception to be held in Vancouver on June 11, 2004.
Dr. Noujaim is a Professor Emeritus of the University of Alberta.
He has been involved in the startup of several biotechnology
companies, is co-founder of Biomira Inc. and founder of ViRexx
Medical Corp. Dr. Noujaim serves on numerous corporate and
scientific advisory boards and is an inventor on over 100 pending
and issued patents.
AltaRex Medical Corp. is focused on the research, development and
commercialization of foreign antibodies that modulate the immune
system for the treatment of certain cancers and other diseases
where there exists an unmet medical need. Additional information
about AltaRex Medical Corp. can be found on its website at
www.altarex.com.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM